Definitive Diagnostics improves cancer testing accuracy with an advanced blood test that eliminates unnecessary biopsies while accelerating treatment for those who need it.

Pictured - Ellis Malovany

Points of Differentiation

First-of-Its-Kind Confirmatory Blood Test: Resolves uncertainty in mammogram results.

Unmatched Accuracy: 99% sensitivity, 97% specificity, and 98% tissue-of-origin accuracy.

AI-Augmented Protein Analysis: Combines immune response markers and AI insights for superior performance at a lower cost than DNA-based alternatives.

Supplementary Images

Team Video

Team

Alan Harris, NYU Langone Health

Ellis Malovany

Robert Puskas

Steve Bolland

Contact us

Days :
Hours :
Minutes :
Seconds


Take your startup further, faster
with NYU's Premier Venture Competition

NYU Entrepreneurs Challenge

APPLICATION CLOSING

DEADLINE: SUNDAY DECEMBER 1 @ 11:59 PM EST

Days :
Hours :
Minutes :
Seconds


See NYU's top startups
of Face off for $225K In Seed funding

NYU Entrepreneurs Challenge

Final Pitch Off & Awards

Friday, April 26th